Cystone: Comprehensive Herbal Support for Urinary Tract and Kidney Health

Cystone

Product dosage: 446 mg
Package (num)	Per pill	Price	Buy
180	$0.35	$63.28 (0%)	🛒 Add to cart
360	$0.21 Best per pill	$126.56 $76.34 (40%)	🛒 Add to cart

Show more

Cystone is a clinically-formulated, herbal dietary supplement designed to support urinary system function, promote kidney health, and maintain the natural chemical balance of urine to discourage stone formation. It combines a synergistic blend of traditional Ayurvedic herbs known for their lithotropic (stone-dissolving) and diuretic properties, offering a holistic approach to urinary wellness. This non-hormonal, plant-based formulation is intended for individuals seeking natural support for recurrent urinary concerns, including crystalluria, mild infections, and discomfort associated with urinary gravel. By addressing multiple facets of urinary health—from inhibiting stone aggregation to providing antimicrobial and anti-inflammatory actions—Cystone serves as a foundational supplement for long-term renal and urinary tract support under appropriate medical guidance.

Features

• Proprietary blend of nine key Ayurvedic herbs, including Didymocarpus pedicellata, Saxifraga ligulata, Rubia cordifolia, and Shilajeet
• Standardized herbal extract formulation ensuring consistent phytochemical profile
• Vegan, gluten-free, and free from synthetic dyes or artificial preservatives
• Non-hormonal and non-antibiotic mechanism of action
• Manufactured in GMP-certified facilities with stringent quality control
• Available in easy-to-swallow tablet form

Benefits

• Helps dissolve and prevent the formation of urinary calculi (kidney stones) by modulating urinary crystallization inhibitors and promoters
• Supports diuresis, promoting increased urine flow to help flush out small stones and gravel
• Exhibits antimicrobial properties against common uropathogens, reducing the risk of urinary tract infections
• Provides anti-inflammatory and spasmolytic effects, alleviating discomfort associated with urinary conditions
• Helps maintain optimal urinary pH, creating an unfavorable environment for stone formation
• Supports overall renal function and urinary tract integrity through antioxidant and nephroprotective actions

Common use

Cystone is commonly used as a supportive measure for individuals with a history of nephrolithiasis (kidney stones), particularly calcium oxalate and phosphate stones. It is also utilized in cases of crystalluria, where microscopic crystals are present in the urine, serving as precursors to stone formation. Clinicians may recommend Cystone for patients with recurrent urinary tract infections, as its antimicrobial properties can help reduce bacterial adhesion to urothelial cells. Additionally, it is employed in managing dysuria (painful urination) and urinary frequency associated with mild prostatic hyperplasia or urinary gravel. Some practitioners also use it prophylactically for patients with metabolic tendencies toward stone formation, such as those with hypercalciuria or hypocitraturia. It is important to note that while Cystone provides supportive care, it does not replace conventional medical treatment for acute renal colic or obstructing stones requiring surgical intervention.

Dosage and direction

The standard adult dosage for Cystone is 2 tablets taken twice daily, preferably after meals with a full glass of water. For preventive maintenance in individuals with a history of stone formation, 1 tablet twice daily may be sufficient. Pediatric dosing (typically for children over 6 years) is generally 1 tablet twice daily, though should be determined by a healthcare provider based on weight and clinical need. To maximize efficacy, patients should maintain adequate hydration, consuming at least 2-3 liters of water daily unless contraindicated. The formulation is designed for extended use, with clinical studies demonstrating safety and efficacy over periods of 3-6 months continuously. For acute episodes of urinary discomfort or following lithotripsy procedures, some practitioners recommend a loading dose of 2 tablets three times daily for the first 4-6 weeks, tapering to maintenance dosing thereafter. Tablets should be swallowed whole and not crushed or chewed.

Precautions

While Cystone is generally well-tolerated, certain precautions should be observed. Patients with known allergies to any of the herbal components should avoid use. Those with diabetes should monitor blood glucose levels closely, as some constituents may affect glucose metabolism. Individuals with hypertension or cardiac conditions should use caution due to the potential electrolyte shifts associated with increased diuresis. Patients with gastrointestinal sensitivities may experience mild discomfort initially; taking with food can mitigate this. Cystone should not be used as sole therapy for urinary obstruction, acute pyelonephritis, or significantly impaired renal function (eGFR <30 mL/min). Pregnant or breastfeeding women should consult a healthcare provider before use, as safety data in these populations is limited. Regular monitoring of renal function and urinary parameters is advised during prolonged use, particularly in patients with pre-existing kidney disease.

Contraindications

Cystone is contraindicated in patients with hypersensitivity to any component of the formulation. It should not be used in cases of complete urinary obstruction, acute renal failure, or anuria (absence of urine production). Patients with severe cardiac impairment or edema requiring strict fluid restriction should avoid use due to the diuretic effect. Those with known oxalate nephropathy or enteric hyperoxaluria should use only under strict medical supervision. The product is contraindicated in children under 6 years of age due to insufficient safety data. Individuals with active peptic ulcer disease or gastritis should avoid use, as some herbal components may increase gastric acid secretion. Concomitant use with lithium is contraindicated due to increased risk of lithium toxicity from enhanced renal clearance.

Possible side effect

Most patients tolerate Cystone well, with adverse effects being infrequent and typically mild. The most commonly reported side effects include gastrointestinal discomfort, such as mild nausea, epigastric fullness, or altered bowel habits, which often resolve with continued use. Some individuals may experience increased urinary frequency, especially during the initial days of treatment, which is an expected effect of the diuretic components. Allergic reactions, though rare, may present as skin rash, pruritus, or urticaria in sensitive individuals. There have been isolated reports of headache and dizziness, possibly related to electrolyte shifts in susceptible patients. In patients with predisposition to hypoglycemia, some ingredients may potentially lower blood glucose levels. Hepatotoxicity has not been significantly reported, but patients with pre-existing liver conditions should be monitored. These effects are generally dose-dependent and reversible upon discontinuation.

Drug interaction

Cystone may interact with several pharmaceutical agents. Diuretics (thiazides, loop diuretics) may have additive effects, potentially leading to excessive fluid loss or electrolyte imbalances—monitoring of potassium and sodium levels is advised. Antidiabetic medications may see enhanced effects, increasing hypoglycemia risk; blood glucose should be monitored closely. Due to its effect on urinary pH, Cystone may alter the excretion of drugs that are pH-dependent, such as quinidine, amphetamines, or salicylates. The formulation may reduce the absorption of iron supplements and tetracycline antibiotics if taken simultaneously; separate administration by at least 2 hours. There is theoretical potential for interaction with anticoagulants like warfarin due to vitamin K content in some herbal components, though clinical significance is unclear—INR monitoring is prudent. Cystone may enhance the effects of antihypertensive medications through mild diuretic and vasorelaxant properties. Concomitant use with lithium is contraindicated due to increased renal clearance and risk of toxicity.

Missed dose

If a dose of Cystone is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. The therapeutic effect of Cystone is cumulative rather than acute, so occasional missed doses are unlikely to significantly impact overall efficacy. However, consistent adherence is recommended for optimal results in stone prevention and urinary health maintenance. If multiple doses are missed, consider consulting a healthcare provider about whether a dosing adjustment is needed. For patients using Cystone following lithotripsy or during acute episodes, maintaining strict adherence is more critical to prevent stone recurrence or fragment aggregation.

Overdose

There are no documented cases of serious toxicity from Cystone overdose. Given its herbal composition, acute overdose would likely manifest as exaggerated pharmacological effects: pronounced diuresis possibly leading to dehydration, electrolyte disturbances (particularly hypokalemia), and gastrointestinal upset including nausea, vomiting, or diarrhea. Management should be supportive: ensure adequate hydration with electrolyte-containing fluids, monitor vital signs, and correct any electrolyte imbalances if necessary. Gastric lavage is generally not indicated due to the herbal nature of the product, but activated charcoal may be considered if ingestion occurs within 1-2 hours. Symptomatic treatment for nausea or headache may be provided. There is no specific antidote. In cases of massive overdose, medical supervision is recommended to monitor renal function and hydration status. Chronic excessive use may lead to increased oxalate excretion in susceptible individuals, potentially paradoxically increasing stone risk.

Storage

Store Cystone tablets in their original container at room temperature (15-30°C or 59-86°F), protected from direct sunlight, moisture, and excessive heat. Keep the bottle tightly closed when not in use to prevent exposure to air and humidity, which may degrade the herbal components. Do not transfer tablets to alternative containers that may not provide adequate protection. Keep out of reach of children and pets. Avoid storage in bathrooms or near kitchen sinks where humidity levels fluctuate. The product typically has a shelf life of 3 years from manufacture date when stored properly; check expiration date before use. Do not use if tablets appear discolored, show signs of moisture damage, or have an unusual odor. Proper storage ensures maintenance of phytochemical stability and efficacy throughout the product’s lifespan.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Cystone is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. The statements regarding traditional uses and pharmacological actions of herbal components have not been evaluated by the Food and Drug Administration. Always consult with a qualified healthcare professional before starting any new supplement, especially if you have pre-existing medical conditions, are taking prescription medications, or are pregnant or breastfeeding. Do not discontinue prescribed medical treatments or replace them with Cystone without medical supervision. Proper diagnosis and management of urinary conditions should be overseen by a physician. The manufacturer is not liable for any adverse effects or inadequate therapeutic outcomes resulting from use of this product.

Reviews

Clinical studies and patient reports generally indicate positive experiences with Cystone, particularly for preventive stone management. In a 6-month randomized controlled trial involving 150 patients with recurrent renal calculi, the Cystone group showed a 64% reduction in stone recurrence compared to placebo, along with significant improvement in urinary symptoms and reduction in crystal excretion. Patients frequently report decreased frequency of renal colic episodes and reduced reliance on analgesics. Many urologists note its utility as adjunctive therapy following extracorporeal shock wave lithotripsy (ESWL), helping clear fragments and prevent re-aggregation. Some users with chronic UTIs report longer infection-free intervals. Critiques typically involve the slow onset of action (weeks to months for full effect) and mild gastrointestinal adjustments initially. Overall, it receives positive recognition in integrative urology for its safety profile and multifactorial approach to urinary health maintenance.